XTL Biopharmaceuticals : Immediate Report of Meeting

UNITED STATES


SECURITIES AND EXCHANGE COMMISSION


Washington, D.C. 20549


FORM 6-K


Report of...

Related Keywords

United States ,Metsada ,Hadarom ,Israel ,Tel Aviv ,Ramat Gan ,Washington ,American ,Israeli ,Shlomo Shalev ,Doron Turgeman ,Yair Redl ,Somekh Chaikin ,Ronen Kantor ,Bnei Brak ,Alexander Rabinovitch ,Biopharmaceuticals Ltd ,Israeli Securities Authority ,Company Meeting ,Securities Exchange ,Company Form ,American Depositary Shares Of The Company ,Israel Companies Regulations Proof Of Ownership ,Commission File Number ,Israeli Companies Law ,Audit Committee ,Tel Aviv Stock Exchange ,Companies Law ,Foreign Private Issuer Pursuant ,Securities Exchange Act ,Extraordinary General Meeting ,Doron Tikotzky Kantor Gutman ,Amit Gross ,Proxy Statement ,Proxy Card ,Voting Instruction Card ,American Depositary Shares ,Instruction Card ,American Depositary Share ,Israel Time ,Certified Public Accountants ,Directors Qualification ,Social Proxy ,Chief Executive Officer ,Tal Klinger ,Annual Meeting ,Israel Companies Regulations ,General Meetings ,Gurion Street ,Chief Executive ,American Depository Shares ,Deposit Agreement ,New York Mellon ,Record Shareholders ,Deferred Meeting ,Beach Proposal ,